Search results
Chemomab (CMMB) Mid-Stage Study for NASH Meets Primary Goal
Zacks via Yahoo Finance· 1 year agoChemomab Therapeutics, Ltd. CMMB announced that its mid-stage study evaluating CM-101 in...
Cassava (SAVA) Up on Progress With Alzheimers Disease Study
Zacks via Yahoo Finance· 1 year agoCassava (SAVA) made positive progress with simufilam, an oral drug treatment for Alzheimer's disease...
Ned Birkey: Wheat research plot will be planted in the Ida area
The Monroe News via Yahoo News· 2 years agoAt the August 25 Farmer Field Day a number of speakers updated farmers regarding various and timely...
Ethereum Generative Art Challenger Highlight Takes on Art Blocks
Decrypt Media via Yahoo Finance· 11 months agoIn spite of crypto’s enduring winter and the ever-spiraling NFT market, on-chain generative artwork...
Abbott wins FDA approval for Esprit resorbable scaffold
MedTech Dive via Yahoo Finance· 2 months agoDive Brief: Abbott said Monday it has received Food and Drug Administration approval for its Esprit...
Gilgamesh starts subject dosing in major depressive disorder trial
Clinical Trials Arena via Yahoo Finance· 2 months agoGilgamesh Pharmaceuticals has commenced subject dosing in a Phase IIa clinical trial of GM-1020 to...
GigaGen doses first subject in Phase I advanced solid tumour trial
Clinical Trials Arena via Yahoo Finance· 4 weeks agoGrifols subsidiary GigaGen has dosed the first subject in a Phase I clinical trial of GIGA-564, a...
Ultragenyx, Mereo drug reduces fractures in bone disorder study
BioPharma Dive via Yahoo Finance· 6 days agoDive Brief: Ultragenyx Pharmaceutical and Mereo BioPharma on Tuesday said their experimental...
Pipeline Moves: Phase III completion for Corcept’s relaorilant
Clinical Trials Arena via Yahoo Finance· 1 month agoThis week on Pipeline Moves, we kick off by looking at the completion of a Phase III trial by...
Boston Scientific study results support coronary drug-coated balloon in US
MedTech Dive via Yahoo Finance· 8 months agoThe results, shared at TCT 2023, found the company’s drug-coated balloon performed better than an...